来自MSN20 天
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by blocking ...
Medical Xpress21 天
FDA: Veozah, first hormone-free hot flash drug, issued black box warning
The U.S. Food and Drug Administration (FDA ... Veozah was approved in 2023. At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by ...
UPI21 天
FDA issues black box warning for hot flash drug Veozah
The U.S. Food and Drug Administration (FDA ... Veozah was approved in 2023. At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by ...
Becker's Hospital Review20 天
FDA adds liver injury warning for Veozah
The FDA has added a boxed warning to the labeling of Veozah, a medication used to treat hot flashes, highlighting ... a non-hormonal prescription medicine approved in May 2023, is classified ...
Yahoo22 天
FDA places its most serious warning on menopause drug due to risk of liver injury
The FDA says women who are taking ... the company said. Veozah was approved in 2023. It works without hormones to reduce hot flashes by blocking a receptor called neurokinin B, which plays a ...
Yahoo Style Canada20 天
FDA issues black box warning for hot flash drug Veozah
At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by blocking neurokinin B, a receptor involved in the brain's regulation of body ...